Cargando…

A comparison between 2 dilute citrate solutions (15mmol/l vs 18 mmol/l) in continuous renal replacement therapy: the base excess and renal replacement solution (BEARRS) study

Detalles Bibliográficos
Autores principales:	Anstey, CM, Richardson, AC, Campbell, VK
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798354/ http://dx.doi.org/10.1186/2197-425X-3-S1-A842

Ejemplares similares

Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution
por: Jeffrey, Yuen Henry, et al.
Publicado: (2017)

Use of Lifestyle Modifications for Management of a Patient with Severely High Total Cholesterol (> 14 mmol/L) and Triglycerides (> 40 mmol/L)
por: Patel, Janhavi, et al.
Publicado: (2021)

Calcium Fluoride Precipitation and Deposition From 12 mmol/L Fluoride Solutions With Different Calcium Addition Rates
por: Markovic, M, et al.
Publicado: (2009)

Differential temporal profile of lowered blood glucose levels (3.5 to 6.5 mmol/l versus 5 to 8 mmol/l) in patients with severe traumatic brain injury
por: Meier, Regula, et al.
Publicado: (2008)

Would raising the total cholesterol diagnostic cut-off from 7.5 mmol/L to 9.3 mmol/L improve detection rate of patients with monogenic familial hypercholesterolaemia?
por: Futema, M., et al.
Publicado: (2015)

Localized hydroxyl radical generation at mmol/L and mol/L levels in water by photon irradiation
por: Ogawa, Yukihiro, et al.
Publicado: (2018)

Use of Only Oral Rehydration Salt Solution for Successful Management of a Young Infant with Serum Sodium of 201 mmol/L in an Urban Diarrhoeal Diseases Hospital, Bangladesh
por: Chisti, Mohammod J., et al.
Publicado: (2012)

Surprising Hyperkalemia of 10.2 mmol/L in a Patient with Hyperglycemia: A Case Report
por: Czogalla, Jan, et al.
Publicado: (2021)

Severe hyponatraemia (P-Na < 116 mmol/l) in the emergency department: a series of 394 cases
por: Mustajoki, Sami
Publicado: (2023)

TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts
por: Yamrozik, June A, et al.
Publicado: (2009)

Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium
por: Sánchez-González, Carmen, et al.
Publicado: (2018)

Validating Physiological and Biomechanical Parameters during Intermittent Swimming at Speed Corresponding to Lactate Concentration of 4 mmol·L(−1)
por: Arsoniadis, Gavriil G., et al.
Publicado: (2020)

Serum Potassium Levels of 4.5 to Less Than 5.0 mmol/L Are Associated with Better Vascular Function
por: Maruhashi, Tatsuya, et al.
Publicado: (2022)

Premature baby with extreme hyponatraemia (95 mmol per litre): a case report
por: Abelian, Arthur, et al.
Publicado: (2015)

Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)

Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality
por: Pérez Ruiz, Fernando, et al.
Publicado: (2019)

Does fasting plasma glucose values 5.1-5.6 mmol/l in the first trimester of gestation a matter?
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2023)

Association of the time in targeted blood glucose range of 3.9–10 mmol/L with the mortality of critically ill patients with or without diabetes
por: Yu, Guo, et al.
Publicado: (2023)

Evaluation of the Recommended 30 cc/kg Fluid Dose for Patients With Septic Shock and Hypoperfusion With Lactate Greater Than 4 mmol/L
por: Yohannes, Seife, et al.
Publicado: (2023)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

High Triglyceride-Glucose Index is Associated with Poor Cardiovascular Outcomes in Nondiabetic Patients with ACS with LDL-C below 1.8 mmol/L
por: Zhang, Yue, et al.
Publicado: (2022)

Calcium-containing versus calcium-free replacement solution in regional citrate anticoagulation for continuous renal replacement therapy: a randomized controlled trial
por: Wei, Tiantian, et al.
Publicado: (2022)

Maintenance fluids should contain at least 77 mmol sodium per liter for critically ill pediatric patients
por: Karabocuoglu, M, et al.
Publicado: (2006)

One lithium level >1.0 mmol/L causes an acute decline in eGFR: findings from a retrospective analysis of a monitoring database
por: Kirkham, E, et al.
Publicado: (2014)

Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial
por: Yuan, Lu, et al.
Publicado: (2021)

Long-term effects on PTH and mineral metabolism of 1.25 versus 1.75 mmol/L dialysate calcium in peritoneal dialysis patients: a meta-analysis
por: Jin, Liqin, et al.
Publicado: (2019)

Efficacy and safety of sodium zirconium cyclosilicate in patients with baseline serum potassium level ≥ 5.5 mmol/L: pooled analysis from two phase 3 trials
por: Amin, Alpesh N., et al.
Publicado: (2019)

Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013)

Citrate for continuous renal replacement therapy: safer, better and cheaper
por: Oudemans-van Straaten, Heleen M
Publicado: (2014)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients
por: O'Brien, Zachary, et al.
Publicado: (2022)

The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol/L
por: Wang, Yue, et al.
Publicado: (2023)

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Magnesium profiles in renal replacement therapy (rrt) on icu: citrate CVVH (CICVVH) vs. intermittent haemodialysis (IHD)
por: Billiet, N, et al.
Publicado: (2015)

Preventing continuous renal replacement therapies (CRRT)-induced hypophosphatemia using a phosphate-containing CRRT solution in the setting of regional citrate anticoagulation
por: Pistolesi, V, et al.
Publicado: (2014)

Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid
por: Morabito, S, et al.
Publicado: (2012)

Regional citrate anticoagulation in CVVH: A new protocol combining citrate solution with a phosphate-containing replacement fluid
por: Morabito, Santo, et al.
Publicado: (2013)

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017)

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes
Publicado: (2016)

Optimizing citrate dose for regional anticoagulation in continuous renal replacement therapy: measuring citrate concentrations instead of ionized calcium?
por: Honore, Patrick M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f001h3rd2isqtkc62qou8ksgqs